Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA – California’s first statewide trade group for biotech   Chapter […]

Read More

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part […]

Read More

Event Recap: How J&J Promotes Innovation

By Dr. Karen Ring, Big3Bio Events Correspondent How exactly does one of the largest pharmaceutical companies in the world promote scientific innovation through proactive collaboration and investment? This month’s BioScience Forum addressed that question by detailing the structure and focus of Johnson & Johnson (J&J) in an event featuring Senior Director for New Ventures, J&J Innovation, Thorsten Melcher. […]

Read More

Event Recap: Insights on the CRISPR/Cas9 Genome Editing Revolution

By Dr. Karen Ring, Big3Bio Events Correspondent It’s a pretty exciting time in the world of science. Stem cell therapies are entering human trials, CAR-T cells are bringing new hope to immuno-oncology, and advancements in genome editing technologies have put gene therapy back on the table. From a therapeutic perspective, the CRISPR/Cas9 genome editing system is […]

Read More

International Event Recap: BIO 2015 in Philadelphia

By Dr Kristophe Diaz, Big3Bio East Coast Consultant This year’s BIO Convention was held in Philadelphia at the Pennsylvania Convention Center, and the 150,000 square feet of convention space gave 1,800 exhibitors a chance to showcase their technologies, capabilities, and, for many countries and 47 states and regions, an opportunity to share a snapshot of […]

Read More

The Fascinating Saga of Elizabeth Holmes

From Nuviun.com: “In a 3-part series, Gisele Waters dives into the amazing world of Elizabeth Holmes, and the paradigm shift that her company, Theranos, is beginning to make around the consumerization of healthcare.” An excerpt: “Elizabeth Holmes has stealthily and steadily set up an operations infrastructure to make one of the biggest impacts on healthcare and […]

Read More

Event Recap: The Business of Personalized Medicine Summit

The Business of Personalized Medicine Recap of The Business of Personalized Medicine Summit, Sept. 9, 2014 Over the past 15 years, “personalized medicine” has become a buzz-phrase bandied about quite often. Yet with the recent advances in genomic sequencing and the advent of big data, the possibilities in personalized medicine are indeed becoming endless. However, […]

Read More

Our Day With Mission Bay

Big3Bio Intern Trip to Mission Bay As we stepped off of the Muni T-Line, we found ourselves at the start of Gene Friend Way, the threshold of UCSF’s Mission Bay campus. Keeping an eye on our map, we wandered past a small plaza of cafés for hungry medical and grad students and toward Koret Quad. […]

Read More

Special Feature: Q&A With Menghis Bairu, CEO of Serenus Biotherapeutics

Dr. Menghis Bairu is Founder, Chairman, and CEO of Sereneus Biotherapeutics, a specialty biopharmaceutical bringing innovative therapies to Sub-Saharan African markets. Before founding Serenus, Dr. Bairu concurrently served as EVP, Chief Medical Officer & Head of Global Development at Elan plc and president and CEO of Speranza Therapeutics, Elan’s wholly owned subsidiary formed to develop […]

Read More

Event Recap: Randy Scott of Invitae Sees Genetics as the Future of Medicine

By Dr. Karen Ring, Big3Bio Events Correspondent Do you ever wonder when individual genetic testing will become routine? The answer might be sooner than you think. Randy Scott, former CEO of Genomic Health, is the founder of Invitae, a San Francisco-based diagnostic company whose mission is to improve the quality of patient healthcare by providing […]

Read More

Event Recap: Disruption and Opportunity: The Leader Role in Creating the Future of Work

During the first quarter of 2013, Genentech embarked on an initiative within its human resources department to examine the “Future of Work.” Led by Steven Kowalski, Ph.D., principal for executive talent development at Genentech, the collective team effort produced some fascinating insights and recommendations that are shaping human resources’ long term cultural vision and objectives. […]

Read More

Recap: Celebrating Women’s History Month

By Dr. Karen Ring, Big3Bio Events Correspondent The San Francisco Women in Bio (WIB) chapter celebrated Women’s History Month with an event titled “Finding the Path to Your Own Career History”. The first half of the event was hosted at UCSF’s mission bay campus and featured three panels that discussed various operational roles and alternative […]

Read More